BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 20852356)

  • 1. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in functional lipid nanoparticles: from drug delivery platforms to clinical applications.
    Dhayalan M; Wang W; Riyaz SUM; Dinesh RA; Shanmugam J; Irudayaraj SS; Stalin A; Giri J; Mallik S; Hu R
    3 Biotech; 2024 Feb; 14(2):57. PubMed ID: 38298556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases.
    Pandian SRK; Vijayakumar KK; Murugesan S; Kunjiappan S
    Heliyon; 2022 Jun; 8(6):e09575. PubMed ID: 35706935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forward Precision Medicine: Micelles for Active Targeting Driven by Peptides.
    Prencipe F; Diaferia C; Rossi F; Ronga L; Tesauro D
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.
    AlSawaftah N; Pitt WG; Husseini GA
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1028-1049. PubMed ID: 34151199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials.
    Zhao J; Santino F; Giacomini D; Gentilucci L
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32854363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives.
    Tesauro D; Accardo A; Diaferia C; Milano V; Guillon J; Ronga L; Rossi F
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30669445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging.
    Song Y; Li W; Meng S; Zhou W; Su B; Tang L; Zhao Y; Wu X; Yin D; Fan M; Zhou C
    Nanoscale Res Lett; 2018 Nov; 13(1):380. PubMed ID: 30483904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells.
    Wen X; Li J; Cai D; Yue L; Wang Q; Zhou L; Fan L; Sun J; Wu Y
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study.
    Monteiro LOF; Fernandes RS; Oda CMR; Lopes SC; Townsend DM; Cardoso VN; Oliveira MC; Leite EA; Rubello D; de Barros ALB
    Biomed Pharmacother; 2018 Jan; 97():489-495. PubMed ID: 29091899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.
    Petrenko VA; Gillespie JW
    Expert Opin Drug Deliv; 2017 Mar; 14(3):373-384. PubMed ID: 27466706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.
    Wang Y; Xie Y; Oupický D
    Curr Pharmacol Rep; 2016 Feb; 2(1):1-10. PubMed ID: 27088072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
    Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
    Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering strategies for designing targeted cancer therapies.
    Alexander-Bryant AA; Vanden Berg-Foels WS; Wen X
    Adv Cancer Res; 2013; 118():1-59. PubMed ID: 23768509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.
    Perche F; Torchilin VP
    J Drug Deliv; 2013; 2013():705265. PubMed ID: 23533772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting strategies with bispecific antibodies.
    Kontermann RE
    MAbs; 2012; 4(2):182-97. PubMed ID: 22453100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes.
    Meng S; Su B; Li W; Ding Y; Tang L; Zhou W; Song Y; Li H; Zhou C
    Nanotechnology; 2010 Oct; 21(41):415103. PubMed ID: 20852356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
    Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
    J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
    Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
    Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.